+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Treatment of Pre-Induction Tachycardia with beta-Adrenergic Blockade Reduces Mortality after CABG

Treatment of Pre-Induction Tachycardia with beta-Adrenergic Blockade Reduces Mortality after CABG

Anesthesiology Abstracts of Scientific Papers Annual Meeting (2001): Abstract No A-250

Introduction: Previously we reported that pre-induction tachycardia was associated with increased mortality after coronary artery bypass graft surgery (CABG). beta-adrenergic blocker therapy for ischemic heart disease has been associated with improved survival after CABG surgery. The purpose of this study was to observe the impact of beta-adrenergic blockade given in the Operating Room before initiation of cardiopulmonary bypass (CPB). Methods: Data were prospectively collected at 6 medical centers in Northern New England on 5,934 patients undergoing isolated CABG surgery between March, 1995 and June, 2000. Patients who had isolated valve or combined/valve CABG surgery were excluded from this study. Pre-induction heart rate was defined as heart rate upon arrival to the Operating Room and was collected by the anesthesiologist. Patients were divided into two groups as defined by the presence or absence of pre-induction tachycardia. Tachycardia was defined as 80 beats per minute (bpm) or greater. The use of beta-adrenergic blockade during the pre-CPB period was also collected. The pre-CPB period was defined as the time period between arrival in the Operating Room and the onset of CPB. Logistic regression analysis was used to calculate adjusted mortality rates. Results: Fifteen percent of this population (n=880) had tachycardia upon arrival to the Operating Room. The use of beta-blockers was 11.6% in patients with heart rate <80 bpm and 25.5% in patients with heart rate gtoreq 80 bpm. Tachycardic patients receiving beta-blockers were less likely to have a preop EF<40% compared with those not receiving beta-blockers (15.7% vs. 22.3%). The groups were not significantly different in age, percent female, incidence of major comorbid conditions, prior CABG, or priority at surgery. Crude mortality rates among tachycardic patients were 1.3% for those receiving beta-blockade vs. 5.5% among those who did not. After adjustment for patient and disease risk factors, mortality for the tachycardic beta-blocker group was still significantly lower (1.3% with beta-blockers vs. 4.2%, without). No association between mortality and beta-blocker use was seen in patients whose pre-induction heart rate was <80 bpm (mortality rate of 1.6% in patients who received a beta-blocker compared to a mortality rate of 1.8% in patients who did not receive a beta-blocker.) Conclusion: Use of beta-adrenergic blocker therapy prior to CABG surgery is associated with improved in-hospital survival. A similar association was seen in this multicenter prospective study. We observed that tachycardic patients who received beta-blockers in the pre-CPB period had a lower in-hospital mortality rate after CABG than those who did not receive beta-blockers.

(PDF emailed within 1 workday: $29.90)

Accession: 035980584

Download citation: RISBibTeXText

Related references

Beta blockers for CHF. Adrenergic blockade dramatically reduces morbidity and mortality. Postgraduate Medicine 109(3): 49-56, 2001

Acquisition of beta-adrenergic blockade by repeated induction of airway anaphylaxis: changes in beta-adrenergic receptor levels in lung homogenates and beta-adrenergic response in tracheal muscles in guinea pigs with experimental asthma. Nihon Kyobu Shikkan Gakkai Zasshi 23(2): 220-229, 1985

Usefulness of isoproterenol facilitation of ventricular tachycardia induction during extrastimulus testing in predicting effective chronic therapy with beta-adrenergic blockade. American Journal of Cardiology 59(6): 573-577, 1987

Beta-adrenergic blockade in the treatment of exercise-induced paroxysmal ventricular tachycardia. Circulation 32(5): 778-781, 1965

Reduction of mortality, sudden death and non-fatal reinfarction with beta-adrenergic blockers in survivors of acute myocardial infarction: a new hypothesis regarding the cardioprotective action of beta-adrenergic blockade. American Journal of Cardiology 66(16): 66g-70g, 1990

Beta adrenergic blockade in the treatment of sustained ventricular tachycardia or ventricular fibrillation. Pacing and Clinical Electrophysiology 19(7): 1026-1035, 1996

Beta adrenergic receptor blockade : a self-limited phenomenon explaining the benignancy of acute poisoning with beta adrenergic inhibitors. Report of a series of 40 patients seen at the Fernand-Widal Toxicology Center, with a 0% mortality rate. La Semaine des Hopitaux 58(17): 1073-1076, 1982

Effects of beta adrenergic blockade on the cardiovascular responses to ventricular tachycardia. Acta Cardiologica 21(4): 477-483, 1966

Beta adrenergic blockade reduces utilitarian judgment. 2012

Beta adrenergic blockade reduces utilitarian judgement. Biological Psychology 92(2): 323-328, 2013

Beta-adrenergic blockade in the management of acute thyrotoxic crisis, tachycardia and arrhythmias. Postgraduate Medical Journal 43(506): 756-762, 1967

Paroxysmal tachycardia induced by physical exertion. Effects of beta-adrenergic blockade. Bollettino Della Societa Italiana di Cardiologia 15(1): 32-41, 1970

Vagally induced tachycardia in atropinized dogs: effect of beta-adrenergic blockade. European Journal of Pharmacology 24(3): 329-333, 1973

Chloralose induced tachycardia in neonatal lambs role of beta adrenergic blockade. Pediatric Research 25(4 PART 2): 66A, 1989